{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 4
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "city": "Denver",
      "advisory_committee_description": "Cardiovascular",
      "address_1": "110 16th Steet Suite 1400 #104",
      "address_2": "",
      "statement_or_summary": "Summary",
      "product_code": "QXZ",
      "openfda": {
        "registration_number": [
          "3017167291"
        ],
        "fei_number": [
          "3017167291"
        ],
        "device_name": "Adjunctive Epicardial Vascular Physiologic Status Indicator",
        "medical_specialty_description": "Cardiovascular",
        "regulation_number": "870.2200",
        "device_class": "2"
      },
      "zip_code": "80218",
      "applicant": "Cleerly, Inc.",
      "decision_date": "2023-09-08",
      "decision_code": "SESE",
      "country_code": "US",
      "device_name": "Cleerly ISCHEMIA",
      "advisory_committee": "CV",
      "contact": "Candice  Bautista-Biddle",
      "expedited_review_flag": "",
      "k_number": "K231335",
      "state": "CO",
      "date_received": "2023-05-08",
      "review_advisory_committee": "CV",
      "postal_code": "80218",
      "decision_description": "Substantially Equivalent",
      "clearance_type": "Traditional"
    }
  ]
}